Minimization of drug-drug interaction risk and candidate selection in a natural product-based class of gamma-secretase modulators

被引：5
|
作者：
Hubbs, Jed L. [1 ]
Fuller, Nathan O. [1 ]
Austin, Wesley F. [1 ]
Shen, Ruichao [1 ]
Ma, Jianguo [1 ]
Gong, Zhen [2 ]
Li, Jian [2 ]
Mckee, Timothy D. [1 ]
Loureiro, Robyn M. B. [1 ]
Tate, Barbara [1 ]
Dumin, Jo Ann [1 ]
Ives, Jeffrey [1 ]
Bronk, Brian S. [1 ]
机构：
[1] Satori Pharmaceut Inc, Cambridge, MA 02139 USA
[2] WuXi AppTec Co Ltd, Shanghai 200131, Peoples R China
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2015年 / 25卷 / 07期
关键词：
Alzheimer's disease; Amyloid-beta; Gamma secretase modulator; Cytochrome P450 3A4; Sterol; Natural product; Semisynthesis; Drug-drug-interactions; OPTIMIZATION;
D O I：
10.1016/j.bmcl.2015.01.051
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Early lead compounds in this gamma secretase modulator series were found to potently inhibit CYP3A4 and other human CYP isoforms increasing their risk of causing drug-drug-interactions (DDIs). Using structure-activity relationships and CYP3A4 structural information, analogs were developed that minimized this DDI potential. Three of these new analogs were further characterized by rat PK, rat PK/PD and rat exploratory toxicity studies resulting in selection of SPI-1865 (14) as a preclinical development candidate. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码：1621 / 1626
页数：6
相关论文
共 50 条
  • [31] Development of Natural Compound Molecular Fingerprint (NC-MFP) with the Dictionary of Natural Products (DNP) for natural product-based drug development
    Myungwon Seo
    Hyun Kil Shin
    Yoochan Myung
    Sungbo Hwang
    Kyoung Tai No
    Journal of Cheminformatics, 12
  • [32] Drug-Drug Interaction Risk Assessment of Esaxerenone as a Perpetrator by In Vitro Studies and Static and Physiologically Based Pharmacokinetic Models
    Yamada, Makiko
    Ishizuka, Tomoko
    Inoue, Shin-ichi
    Rozehnal, Veronika
    Fischer, Thomas
    Sugiyama, Daisuke
    DRUG METABOLISM AND DISPOSITION, 2020, 48 (09) : 769 - 777
  • [33] PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODELING TO EVALUATE DRUG-DRUG INTERACTION (DDI) RISK OF ALECTINIB.
    Cleary, Y.
    Gertz, M.
    Morcos, P. N.
    Youdim, K.
    Fowler, S.
    Yu, L.
    Sekiguchi, N.
    Takanashi, K.
    Kaneko, A.
    Phipps, A.
    Parrott, N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S40 - S40
  • [34] BioCores: identification of a drug/natural product-based privileged structural motif for small-molecule lead discovery
    Roman Kombarov
    Andrea Altieri
    Dmitry Genis
    Mikhail Kirpichenok
    Valeriy Kochubey
    Natalia Rakitina
    Zoya Titarenko
    Molecular Diversity, 2010, 14 : 193 - 200
  • [35] Building Natural Product-Based Libraries for Drug Discovery: Challenges and Opportunities from a Brazilian Pharmaceutical Industry Perspective
    Conrado, Gabrielly Galdino
    da Rosa, Rafael
    Reis, Romulo Dragani
    Pessa, Lisandra Ravanelli
    REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY, 2024, 34 (04): : 706 - 721
  • [36] BioCores: identification of a drug/natural product-based privileged structural motif for small-molecule lead discovery
    Kombarov, Roman
    Altieri, Andrea
    Genis, Dmitry
    Kirpichenok, Mikhail
    Kochubey, Valeriy
    Rakitina, Natalia
    Titarenko, Zoya
    MOLECULAR DIVERSITY, 2010, 14 (01) : 193 - 200
  • [37] Natural product-based anti-HIV drug discovery and development facilitated by the NCI developmental therapeutics program
    Yang, SS
    Cragg, GM
    Newman, DJ
    Bader, JP
    JOURNAL OF NATURAL PRODUCTS, 2001, 64 (02): : 265 - 277
  • [38] Metabolomics-Based Elucidation of Therapeutic Mechanism of Luteolin Towards Autism in Children and Relevant Drug-Drug Interaction Risk
    Sun, Xingzhen
    Li, Chaoyang
    Wang, Xiang
    Zhang, Rongrong
    Hong, Ze
    LATIN AMERICAN JOURNAL OF PHARMACY, 2015, 34 (03): : 590 - 592
  • [39] Machine-learning based drug-drug interaction prediction identifies acetylsalicylic acid as risk for cardiovascular events during migraine treatment
    Gecse, Kinga
    Duc Anh Nguyen
    Juhasz, Gabriella
    Mamitsuka, Hiroshi
    Petschner, Peter
    CEPHALALGIA, 2023, 43 (1supp) : 76 - 76
  • [40] Mechanism-based inactivation of human cytochrome P450 enzymes: strategies for diagnosis and drug-drug interaction risk assessment
    Venkatakrishnan, K.
    Obach, R. S.
    Rostami-Hodjegan, A.
    XENOBIOTICA, 2007, 37 (10-11) : 1225 - 1256
12345